SEC Form 5 · accession 0001185185-15-000343

Entia Biosciences, Inc. · ERGO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Pres., CEO, Acting CFO · Director · 10% Owner

Period of report

Dec 31, 2014

Accepted (ET)

Feb 17, 2015 · 8:15 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001408299

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Oct 24, 2014	G	30,000	$0.30	D	4,157,200	D
Common Stock	Oct 24, 2014	G	8,000	$0.30	D	4,157,200	D
Common Stock	Oct 24, 2014	G	1,200	$0.30	D	4,157,200	D
Common Stock	Oct 25, 2014	G	1,200	$0.30	D	4,157,200	D
Common Stock	Oct 24, 2014	G	1,200	$0.30	D	4,157,200	D
Common Stock	Oct 25, 2014	G	1,000	$0.30	D	4,157,200	D
Common Stock	Oct 25, 2014	G	1,000	$0.30	D	4,157,200	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Incentive stock option^F1	$0.40	Sep 29, 2014	A	175,000	A	Nov 1, 2015	Sep 29, 2021	Common Stock	175,000	175,000	D